Aurobindo Pharma has provided an update regarding the transfer of shares of CuraTeQ Biologics s.r.o., held by Helix Healthcare B.V., to Curateq Biologics B.V. The share transfer is expected to be completed on or before November 30, 2025, pending receipt of updated business register from authorities in The Netherlands.
Share Transfer Update
Aurobindo Pharma has announced an update on the transfer of shares related to its subsidiary, CuraTeQ Biologics s.r.o. The transaction involves a transfer from Helix Healthcare B.V. to Curateq Biologics B.V., which are wholly owned subsidiaries of the company.
Expected Completion
The company anticipates the share transfer to be finalized on or before November 30, 2025. This timeline is contingent upon receiving updated business registry information from the relevant authorities in The Netherlands, reflecting the share transfer. The initial announcement regarding the binding agreement for this transfer was made on July 29, 2025.
Source: BSE
